47 results on '"Garcia, Ruel T"'
Search Results
2. Mutations in HBV DNA Polymerase Associated With Nucleos(t)ide Resistance Are Rare in Treatment-naive Patients
3. Significant Prevalence of Histologic Disease in Patients With Chronic Hepatitis B and Mildly Elevated Serum Alanine Aminotransferase Levels
4. Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis
5. Unsedated ultrathin EGD is well accepted when compared with conventional sedated EGD: a multicenter randomized trial
6. Racial differences in effectiveness of α-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis
7. Mo1896 Chronic Hepatitis B (CHB) Treatment Eligibility and Actual Treatment Rates at Community Gastroenterology Clinics and Primary Care Clinics
8. Mo1893 Evaluation of Treatment-Eligibility for Antiviral Therapy During Follow-up in Chronic Hepatitis B Patients Initially Ineligible for Treatment
9. Su2044 Incidence of Hepatocellular Carcinoma (HCC) in Non-Cirrhotic and Cirrhotic Patients With Chronic Hepatitis B (CHB): Results of a Multicenter Cohort Study
10. Sa1087 Less Established Risk Factors are Common in Asian Americans With Hepatitis C Virus: A Case-Control Study
11. Sa1043 Outcomes of Oral Antiviral Treatment for Chronic Hepatitis B (CHB) in Routine Clinical Practice
12. Sa1003 High Prevalence of Hepatitis C Virus in Ethnically Diverse Community Patients With Non-Liver Related Gastrointestinal Complaints
13. HBV Precore C1858T Mutation Does Not Share Similar Clinical or Virologic Characteristics With Other Precore Mutants
14. Hepatitis B Virus (HBV) Reverse Transcriptase Mutation Prevalence Was Low in Treatment-NaïVE Patients With Chronic Hepatitis B (CHB) Using Inno-Lipa HBV DR3 in a Prospective Multicenter Study
15. Rapid Complete Viral Suppression (CVS) With Entecavir (ETV) in Adefovir (ADV)-Experienced Patients: Interim Report for a Multicenter Study
16. Long-Term Treatment Response to Entecavir and Adefovir in Treatment-NaïVE Chronic Hepatitis B E Antigen-Negative Patients in a Community Setting
17. Treatment of Chronic Hepatitis B Patients According to Current Guidelines: A Community-Based Study
18. Incidence and Predictors of Hepatitis B E Antigen (HBeAg) Seroconversion in Chronic Hepatitis B (CHB) Patients Treated With Anti-HBV Therapy in Routine Clinical Practice
19. Annual Incidence for Hepatocellular Carcinoma (HCC) in Non-Cirrhotic Patients With Chronic Hepatitis B (CHB) and Cirrhotic Patients of All Etiologies
20. High Rate of Recurrent Hepatitis B Viremia Following Treatment-Induced Hepatitis B E Antigen (HBeAg) Seroconversion
21. Proportion of Patients Who Were Previously Ineligible for Anti-HBV Therapy Who Became Eligible After 12 Months of Follow-up: Application of U.S. Panel and AASLD Guidelines
22. EUS-guided FNA for GI stromal tumors: caveat lector
23. T1967 Asian Ethnicity is a Significant Predictor for Viral Dominance by HBV in HBV/HCV Co-Infected Patients: A Multicenter, Matched Case-Control Study
24. M1903 Long-Term Outcome of Treatment-NaïVE Chronic Hepatitis B (CHB) E Antigen-Negative Treated With Entecavir 0.5 Mg (ETV) or Adefovir 10 Mg (ADV) in a Real-Life Community Setting
25. M1893 Hepatitis B Virus Reverse Transcriptase Mutations Were Not Detected in Treatment-NaïVE Patients With Chronic Hepatitis B Using Inno Lipa HBV DR3: A Prospective Multicenter Study
26. M1892 Hepatitis B-E Antigen Positive (HBeAg+) Chronic Hepatitis B (CHB) Patients With Precore (PC) and Basic Core Promoter (BCP) Mutations
27. 636 High Rate of Complete Viral Suppression With Combination Therapy With Tenofovir Using Entecavir or Lamivudine/Emtricitabine in Patients With Chronic Hepatitis B and Prior Monotherapy Failure
28. 634 Treatment Efficacy of Entecavir (ETV) Therapy in Patients Previously Treated With Adefovir (ADV): Interim Report for a Multicenter Study
29. 314 Randomized Controlled Trial of Pegylated Interferon-Alpha 2a and Ribavirin in Patients With Treatment-NaïVE Chronic Hepatitis C Genotype 6
30. 80 Hepatocellular Carcinoma Incidence in a Cohort of 981 U.S. Patients With Chronic Hepatitis B Without Cirrhosis and Patients With Cirrhosis of All Etiologies
31. W1813 Incidences of Renal Dysfunction in Chronic Hepatitis B (CHB) Patients Treated with Adefovir Dipivoxil (ADV) 10mg
32. W1810 Long-Term Outcome At Year 5 in Chronic Hepatitis B (CHB) Patients Initially Treated with Adefovir Dipivoxil (ADV) in a Real-Life Clinical Setting
33. W1809 Changes in Creatinine Clearance (CrCl) in Chronic Hepatitis B (CHB) Patients Treated with Adefovir Dipivoxil (ADV): A Case-Control Study
34. W1807 Long-Term Outcome of Chronic Hepatitis B Patients Initially Treated with Entecavir in a Real-Life Clinical Setting
35. M1786 Response to Peginterferon (PEG IFN) and Ribavirin (RBV) in Asian Americans and Non-Asian Americans with Chronic Hepatitis C (CHC) in a Real-Life Community Setting: A Multi-Center Study
36. M1777 Poor Adherence to Screening for Hepatocellular Carcinoma (HCC), Especially in Patients with Chronic Hepatitis B (CHB) Without Cirrhosis Compared to Patients with Cirrhosis of All Etiologies
37. 319 Response to Entecavir (ETV) in Patients with Chronic Hepatitis B (CHB) and Prior Suboptimal Response to Adefovir (ADV): Interim Report of a Multicenter Study
38. 11 Treatment Response and Tolerability to Pegylated Interferon (PEG Inf) and Ribavirin (RBV) in Treatment-Naïve Asian American Patients with Chronic Hepatitis C and Genotype 1, 2/3 and 6
39. S2084 Significant Prevalence of Histologic Disease in Chronic Hepatitis B Patients with Mildly Elevated Serum Alanine Aminotrasferase Levels
40. S2076 Age≥35 Years Is a Predictor of Significant Histology in Chronic Hepatitis B (CHB) Patients with Normal ALT Even with Stricter Cut-Offs (≤30 for Men and ≤19 for Women)
41. S2075 Prevalence of HBV DNA Polymerase (B-DNA Pol) Mutations in 345 Patients with Treatment-NaïVe Chronic Hepatitis B (CHB)
42. S2077 Almost Half of the Chronic Hepatitis B (CHB) Patients with Positive HBeAg Have Confirmed Precore and/or Basal Core Promoter (PREC/BCP) Mutations
43. S2071 Vietnamese Patients with Chronic Hepatitis B (CHB) Exhibit Different Viral Genotype Distributions Than Chinese Patients
44. Racial differences in risk for liver cancer in patients with hepatitis C cirrhosis: A multicenter case-control study
45. 1014 Evaluation and outcomes of combination therapy with interferon or peginterferon plus ribavirin in 67 Southeast Asian patients with hepatitis C genotypes 6, 7, 8, and 9
46. Unsedated ultrathin EGD is well accepted by most patients: a randomized trial of unsedated Ultrathin EGD (UT-EGD) vs. sedated Conventional EGD (C-EGD)
47. Vancomycin-resistant enterococci (VRE) spontaneous bacterial peritonitis (SBP)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.